Global Opthalmic Therapeutic Market 2015-2019

Global Opthalmic Therapeutic Market 2015-2019

  • July 2015 •
  • 146 pages •
  • Report ID: 3142676 •
  • Format: PDF
About Ophthalmic Diseases
Ophthalmology is the science of eyes. It is the branch of medicine concerned with the treatment of eye-related diseases and eye defects. Some of the common eye disorders are glaucoma, retinal diseases, conjunctivitis, refractive errors, color blindness, and retinitis. Many of the eye diseases do not show symptoms at early stages. They will be painless with no defect in vision until the disease progresses to an advanced stage. Regular eye checkups must be done to detect the development of any disorder. Proper care and hygiene must be ensured to protect the eyes.

Technavio's analysts forecast the global ophthalmic therapeutic market to grow at a CAGR of 6.53% over the period 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the global ophthalmic therapeutic market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various branded therapies, OTC drugs, and generics along with the drugs used as off-label for the treatment of ophthalmic disorders such as:
- Glaucoma
- Dry eye syndrome
- Retinal disorders such as diabetic retinopathy, macular edema, RVO, and AMD

Technavio's report, Global Ophthalmic Therapeutic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of global ophthalmic therapeutic market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
- Americas

Key Vendors
- Actavis
- Bayer
- F. Hoffmann-La Roche
- Merck
- Novartis
- Pfizer
- Regeneron Pharmaceuticals

Other Prominent Vendors
- Acadia Pharmaceuticals
- AC Immune
- Acorn Biomedical
- Acucela
- Advanced Cell Technology
- Aerie Pharmaceuticals
- Alcon
- Alexion Pharmaceuticals
- Alimera Sciences
- Allergan
- Ampio Pharmaceuticals
- Antisense Therapeutics
- Avalanche Biotechnologies
- BCN Peptides
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Carl Zeiss Meditec
- Eleven Biotherapeutics
- Falcon Pharmaceuticals
- Gilead Sciences
- GlaxoSmithKline
- Glycadia
- Icon Bioscience
- iCo Therapeutics
- Inotek Pharmaceuticals
- Intellect Neurosciences
- Isis Pharmaceuticals
- Kowa Group
- Laboratorios Sophia
- Lexicon Pharmaceuticals
- Lpath
- Neurotech Pharma
- NicOx
- Numoda Capital
- OPKO Health
- Ophthotech Corporation
- Ohr Pharmaceutical
- Otsuka Pharmaceutical
- PanOptica
- Parexel International
- Promedior
- pSivida
- Quark Pharmaceuticals
- R-Tech Ueno
- Santen Pharmaceutical
- Seikagaku
- Senju Pharmaceutical
- Shire
- Sirnaomics
- StemCells
- ThromboGenics
- Valeant Pharmaceuticals

Market Driver
- Increase in Prevalence of Eye Diseases
- For a full, detailed list, view our report

Market Challenge
- Lack of Awareness
- For a full, detailed list, view our report

Market Trend
- Strategic Alliances
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.